Chief Excecutive Officer of IAG, with expertise in actively managing innovation in life science companies, asset positioning, strategy and capital.

Chair of IAG’s Scientifc Advisory Board and expert in global pharmaceutical R&D, developing treatments in immunology, neurology and oncology.

IAG’s CTO and expert in medical image analysis, data mining, algorithm development, medical image and video processing, mathematical, stochastic and forecasting modelling and numerical analysis.

Chairman of IAG and operating partner of ArchiMed, recognized commercial leader in clinical research sector, investor and strategist.

IAG’s COO and drug development veteran with 20+ years of experience growing teams and scaling operations.

IAG’s CFO and Investment Professional with 20+ years of Expertise in Life science Industry.

NED and global client adviser for healthcare.

Robert is heavily involved into building a diversified investment portfolio composed of early to market stage products.

Member of IAG’s Scientific Advisory Board, NED and lead in precision medicine clinical research.